We are LOTTE BIOLOGICS
A new company, built on 80 years of tradition
We embody our core values of being Inspired by Science, Embracing Diversity, Fostering Talent, and Connecting Lives
Our mission is to be the most trusted partner in the industry, with high standards of quality and continuous innovation, to reliably deliver benefits for patients worldwide
We deliver therapies that make a Healthier World
LOTTE Biologics has made the East Syracuse, NY facility its North American hub of operations. In addition to our existing and expanding biologics capabilities, we’re proud to announce the creation of our Antibody Drug Conjugates (ADC) Manufacturing Center. Here we will make ADC and other classes of Bioconjugates to bring new therapies to market that save lives. The goal is to create a one-stop platform that offers everything from antibody drug production to chemical drug conjugation, as part of our efforts to become North America’s premier ADC contract manufacturing center.
To make this exciting vision to become a reality, we’re in need of an Associate Director Antibody Drug Conjugate Operations to drive the facility design, build out, start-up, qualification, and manufacturing processes. The ideal candidate will have experience with common downstream unit operations such as tangential flow filtration, dead-end filtration, and protein chromatography, as well as operational experience with customer projects to enable transfer to GMP manufacturing. During facility build and start-up phases this role will influence process and organizational design. As the facility transitions to the release phase, this role will be responsible for onboarding and developing a manufacturing team.
To be successful in this role the following is expected;
We believe that women, people of color, veterans and LGBTQ communities must participate in the work we do, so we strongly encourage applications from people with these identities or who are members of underrepresented communities.
If this is the work that you want to do in a culture of inclusion and excellence with the goal of making our world to be a healthier place, then please apply today!
LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. LOTTE BIOLOGICS entered the biologics CDMO business after acquiring Bristol Myers Squibb’s Syracuse biologics drug substance manufacturing site, as of January 1, 2023!
The newly established organization aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. With initial operations in 1948 in Japan, LOTTE has grown to become the fifth-largest conglomerate corporation in South Korea. LOTTE has various business units, including petro/fine chemicals, food, retail, hotels, electronics, construction, and IT. LOTTE has 30+ global locations across the US, Europe, and Asia.
An Equal Opportunity Employer
We do not discriminate based on race, color, religion, national origin, sex, age, disability, genetic information, or any other status protected by law or regulation. It is our intention that all qualified applicants are given equal opportunity and that selection decisions be based on job-related factors.
Software Powered by iCIMS
www.icims.com